featured
DPP-4 Inhibitors vs Sulfonylureas With Metformin in Type 2 Diabetes Mellitus
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Internal Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus
Ann. Intern. Med 2015 Oct 13;[EPub Ahead of Print], SM Ou, CJ Shih, PW Chao, H Chu, SC Kuo, YJ Lee, SJ Wang, CY Yang, CC Lin, TJ Chen, DC Tarng, SY Li, YT ChenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.